Clinical Social Workers in Cape May, NJ Accepting Medicare
4 Clinical Social Workers found. Showing 1 - 4
 Arnulfo Joseph Vargas, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1289 Lafayette St, #g, Cape May, NJ 08204 Phone: 609-898-4334 Fax: 609-898-4334 |
 Lisa C Borchardt, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1005 Seashore Rd, Cape May, NJ 08204 Phone: 609-972-6054 |
Charlene Diperi, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1 Munro Ave, Cape May, NJ 08204 Phone: 609-898-6610 Fax: 609-898-6962 |
Ms. Karen Elizabeth Vanorden, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1 Munro Avenue, Cape May Va Uscg Tracen, Cape May, NJ 08204 Phone: 609-898-8700 |
News Archive
Dried blood spot samples accurately detect anti-SARS-CoV-2 S glycoprotein antibodies
Using dried blood spot samples (DBS) is an accurate alternative to venous blood in detecting SARS-CoV-2 antibody tests, a new study by immunology experts at the University of Birmingham has found.
Scientists identify hepsin protein's role in breast cancer
Cancers rarely are deadly unless they evolve the ability to grow beyond the tissues in which they first arise. Normally, cells - even early-stage tumor cells - are tethered to scaffolding that helps to restrain any destructive tendencies. But scientists from the University of Helsinki, Finland, and from UCSF have identified a cleaver-wielding protein that frees some tumor cells, allowing them to further misbehave.
Nanoscale whiskers could hold key to creating working human muscle tissue
Minute whiskers of nanoscale dimensions taken from sea creatures could hold the key to creating working human muscle tissue, University of Manchester researchers have discovered.
DoD recommends funding for Synta's STA-9584 for prostate cancer study
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Department of Defense (DoD) has recommended STA-9584, a novel vascular disrupting agent (VDA) currently in pre-clinical development at Synta, be funded for study in advanced prostate cancer.
New gold standard of care for overactive bladder
A major clinical trial finds that a combination of two common medications - tolterodine (Detrol LA) and tamsulosin (Flomax) - works better than either drug alone for men struggling with lower urinary tract symptoms, including tough-to-treat overactive bladder (OAB).
› Verified 9 days ago
Dentists
Occupational Therapists
Pharmacists
Clinical Social Workers
Counselors